Literature DB >> 29387987

Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.

Daniel E Spratt1, Krithika Suresh2, Takahiro Osawa3, Matthew Schipper4,2, William C Jackson4, Ahmed Abugharib4, Amir Lebastchi5, David Smith6, Jeffrey S Montgomery5, Ganesh S Palapattu5,7, L Priya Kunju8, Angela Wu8, Madelyn Lew8, Scott A Tomlins8, Arul M Chinnaiyan8,9,10, Alon Z Weizer5, Khaled S Hafez5, Samuel D Kaffenberger5, Aaron Udager8, Rohit Mehra8,9.   

Abstract

The frequency of co-occurrence between germ cell tumor (GCT) components in non-seminomatous germ cell tumor (NSGCT) orchiectomy specimens and their correlation with histologic findings in subsequent retroperitoneal lymph node dissection (RPLND) specimens have not been well characterized. The objective of the study was to report the first detailed clinicopathologic analysis of NSGCT orchiectomy and RPLND samples to determine the likelihood and agreement of the co-occurrence of GCT components. A total of 118 consecutive patients with NSGCT treated between 1988 and 2012 who underwent both orchiectomy and RPLND at a single academic tertiary care center were analyzed. Statistical analysis of co-occurrence likelihood and agreement of GCT components was performed, both within and between orchiectomy and RPLND specimens. Embryonal carcinoma was the most frequent component present in orchiectomy specimens, and there were multiple significant associations between orchiectomy GCT components; seminoma occurred less frequently with embryonal carcinoma (OR 0.29 [95% confidence interval (CI) 0.11-0.75]; p < 0.01), and teratoma more frequently occurred with choriocarcinoma (OR 9.64 [95% CI 1.22-76.12]; p = 0.01). Presence of teratoma in the orchiectomy specimen predicted for a fourfold increase in distant metastasis on multivariate analysis (HR 4.92 [1.14-18.9]; p = 0.02). The only significant association of co-occurrence in the RPLND specimen was between embryonal carcinoma and teratoma (OR 0.01 [95% CI 0-0.07]; p < 0.001), where it was significantly less likely for them to occur together. Our findings are limited by their retrospective nature. The co-occurrence of GCT components within orchiectomy specimens does not appear to be a completely random process. However, there is less agreement and more randomness between the occurrence of the GCT components in matched orchiectomy and RPLND samples. In this report, we look at the co-occurrence of different GCT components within matched orchiectomy and RPLND pathology specimens and show that co-occurrence is not a completely random process.

Entities:  

Keywords:  Histologic component; Non-seminomatous germ cell tumor (NSGCT); Orchiectomy; Retroperitoneal lymph node dissection (RPLND)

Mesh:

Year:  2018        PMID: 29387987     DOI: 10.1007/s12032-018-1090-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  12 in total

Review 1.  The Role of Postchemotherapy Surgery in Germ Cell Tumors.

Authors:  Lisly Chéry; Atreya Dash
Journal:  Urol Clin North Am       Date:  2015-06-19       Impact factor: 2.241

2.  Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

Authors:  Shilajit D Kundu; Darren R Feldman; Brett S Carver; Amit Gupta; George J Bosl; Robert J Motzer; Dean F Bajorin; Joel Sheinfeld
Journal:  J Urol       Date:  2014-08-20       Impact factor: 7.450

Review 3.  Testicular germ-cell cancer.

Authors:  G J Bosl; R J Motzer
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

4.  Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.

Authors:  L S Freedman; M C Parkinson; W G Jones; R T Oliver; M J Peckham; G Read; E S Newlands; C J Williams
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

Review 5.  Testicular germ-cell tumours in a broader perspective.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

6.  Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin.

Authors:  J J McKendrick; J Theaker; G M Mead
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

7.  Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy.

Authors:  Hikmat A Al-Ahmadie; Brett S Carver; Angel M Cronin; Semra Olgac; Satish K Tickoo; Samson W Fine; Anuradha Gopalan; Jason Stasi; Farhang Rabbani; George J Bosl; Joel Sheinfeld; Victor E Reuter
Journal:  Urology       Date:  2013-10-02       Impact factor: 2.649

Review 8.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 9.  An overview of testicular germ cell tumors.

Authors:  Armita Bahrami; Jae Y Ro; Alberto G Ayala
Journal:  Arch Pathol Lab Med       Date:  2007-08       Impact factor: 5.534

10.  Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.

Authors:  Shi-Ming Tu; Mehmet Asim Bilen; Kenneth R Hess; Russell R Broaddus; Scott Kopetz; Chongjuan Wei; Lance C Pagliaro; Jose A Karam; John F Ward; Christopher G Wood; Priya Rao; Zachary H Tu; Rosale General; Adrienne H Chen; Yago L Nieto; Sai-Ching J Yeung; Sue-Hwa Lin; Christopher J Logothetis; Louis L Pisters
Journal:  Cancer       Date:  2016-03-28       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.